Factorial thinks it can. Great profile of Factorial and its CEO, Siyu Huang, by @jackewingnyt.bsky.social. 🔌💡🔌🚗
www.nytimes.com/2025/05/09/b...
Factorial thinks it can. Great profile of Factorial and its CEO, Siyu Huang, by @jackewingnyt.bsky.social. 🔌💡🔌🚗
www.nytimes.com/2025/05/09/b...
The company plans to initiate a Phase 3 clinical trial for bemdaneprocel (its investigational cell therapy) for #Parkinsons; With RMAT designation, the "exPDite-2" study is expected to begin in the first half of 2025
www.bluerocktx.com/bluerock-the...
The company plans to initiate a Phase 3 clinical trial for bemdaneprocel (its investigational cell therapy) for #Parkinsons; With RMAT designation, the "exPDite-2" study is expected to begin in the first half of 2025
www.bluerocktx.com/bluerock-the...